| Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial YH Kim, M Bagot, L Pinter-Brown, AH Rook, P Porcu, SM Horwitz, ... The lancet oncology 19 (9), 1192-1204, 2018 | 524 | 2018 |
| First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation R Romee, S Cooley, MM Berrien-Elliott, P Westervelt, MR Verneris, ... Blood, The Journal of the American Society of Hematology 131 (23), 2515-2527, 2018 | 350 | 2018 |
| Stevens-Johnson syndrome/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States RG Micheletti, Z Chiesa-Fuxench, MH Noe, S Stephen, M Aleshin, ... Journal of Investigative Dermatology 138 (11), 2315-2321, 2018 | 116 | 2018 |
| Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome/toxic epidermal necrolysis—ABCD-10 MH Noe, M Rosenbach, RA Hubbard, A Mostaghimi, AR Cardones, ... JAMA dermatology 155 (4), 448-454, 2019 | 89 | 2019 |
| Update on treatment of cutaneous T-cell lymphoma JM Gardner, KG Evans, A Musiek, AH Rook, EJ Kim Current opinion in oncology 21 (2), 131-137, 2009 | 60 | 2009 |
| Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications AC Hsi, SJ Lee, IS Rosman, KR Carson, A Kelley, V Viele, X Pang, ... Journal of the American Academy of Dermatology 72 (1), 159-167, 2015 | 50 | 2015 |
| Chronic inflammation promotes skin carcinogenesis in cancer-prone discoid lupus erythematosus A Zaalberg, SM Tuchayi, AH Ameri, KH Ngo, TJ Cunningham, JP Eliane, ... Journal of Investigative Dermatology 139 (1), 62-70, 2019 | 44 | 2019 |
| Ipilimumab-associated Sweet syndrome in a patient with high-risk melanoma RL Kyllo, MK Parker, I Rosman, AC Musiek Journal of the American Academy of Dermatology 70 (4), e85-e86, 2014 | 42 | 2014 |
| Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma C Querfeld, TM Kuzel, YH Kim, P Porcu, M Duvic, A Musiek, AH Rook, ... Leukemia & lymphoma 52 (8), 1474-1480, 2011 | 38 | 2011 |
| Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma JM Andrews, JA Schmidt, KR Carson, AC Musiek, N Mehta-Shah, ... EBioMedicine 46, 170-183, 2019 | 34 | 2019 |
| Mogamulizumab-associated cutaneous granulomatous drug eruption mimicking mycosis fungoides but possibly indicating durable clinical response L Chen, KR Carson, KW Staser, N Mehta-Shah, A Schaffer, IS Rosman, ... JAMA dermatology 155 (8), 968-971, 2019 | 34 | 2019 |
| United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic JA Zic, W Ai, OE Akilov, JB Carter, M Duvic, F Foss, M Girardi, AA Gru, ... Journal of the American Academy of Dermatology 83 (2), 703, 2020 | 31 | 2020 |
| Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium B Lu, L Geng, A Musiek, J Tan, C Cao, E Donnelly, G McMahon, H Choy, ... International Journal of Radiation Oncology* Biology* Physics 58 (3), 844-850, 2004 | 30 | 2004 |
| The PROVe study: US real-world experience with chlormethine/mechlorethamine gel in combination with other therapies for patients with mycosis fungoides cutaneous T-cell lymphoma EJ Kim, J Guitart, C Querfeld, M Girardi, A Musiek, OE Akilov, JT Angello, ... American Journal of Clinical Dermatology 22, 407-414, 2021 | 28 | 2021 |
| Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial RA Cowan, JJ Scarisbrick, PL Zinzani, JP Nicolay, L Sokol, ... Journal of the European Academy of Dermatology and Venereology 35 (11), 2225 …, 2021 | 26 | 2021 |
| Methotrexate-induced cutaneous ulceration in 3 nonpsoriatic patients: report of a rare side effect HA Lewis, KM Nemer, RJ Chibnall, AC Musiek JAAD case reports 3 (3), 236-239, 2017 | 26 | 2017 |
| Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: preliminary findings from a prospective observational study EJ Kim, L Geskin, J Guitart, C Querfeld, M Girardi, A Musiek, DR Mink, ... Journal of the American Academy of Dermatology 83 (3), 928-930, 2020 | 25 | 2020 |
| Health‐related quality of life and economic implications of cutaneous T‐cell lymphoma YR Semenov, AR Rosenberg, C Herbosa, N Mehta‐Shah, AC Musiek British Journal of Dermatology 182 (1), 190-196, 2020 | 23 | 2020 |
| High-throughput mitochondrial genome screening method for nonmelanoma skin cancer using multiplexed temperature gradient capillary electrophoresis W Girald-Rosa, RA Vleugels, AC Musiek, JE Sligh Clinical chemistry 51 (2), 305-311, 2005 | 23 | 2005 |
| Graft-versus-host disease after simultaneous pancreas–kidney transplantation: a case report and review of the literature AP Rossi, BA Bone, AR Edwards, MK Parker, RBD Santos, J Hagopian, ... American Journal of Transplantation 14 (11), 2651-2656, 2014 | 22 | 2014 |
